Why the study?
Does bromocriptine improve symptoms in a young man with Neuroleptic Malignant Syndrome induced by trifluperidol?
Does bromocriptine improve symptoms in a young man with Neuroleptic Malignant Syndrome induced by trifluperidol?
Bromocriptine may be an effective treatment for Neuroleptic Malignant Syndrome induced by trifluperidol.
Bromocriptine may warrant consideration in trifluperidol-induced NMS; hypothesis-generating and requires prospective trials before practice change.
In a case of NMS subsequent to administration of trifluperidol to a young man, the patient responded remarkably quickly to bromocriptine. The authors point out the deficiencies in the diagnostic criteria, which need further refinement for a better understanding of the syndrome.
No takes yet. Share an insight, caveat, or question.
Singh et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: